Charles River to fuel hit discovery with AstraZeneca high-throughput collaboration
After collaborating with AstraZeneca Charles River is now looking forward to strengthening its high-throughput screening capabilities (HTC) with the help of highly advance AstraZeneca technology. Now the company is able to offer the clients access to a screening facility with highly high-resolution, flexible, automated screening platforms. The collaboration has also enabled Charles River Laboratories to offer state-of-the-art assay detection platforms for label-free and imaging-based assays, along with the ability to run novel technologies, including acoustic mass spectrometry.
JDRF an...
